Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1)
- Product Code: 140419
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
This antibody is primarily used in therapeutic research targeting inflammatory and metabolic diseases. It modulates the activity of PGLYRP1 (Peptidoglycan Recognition Protein 1), a protein involved in innate immune responses, making it a candidate for treating conditions such as type 2 diabetes, obesity-related inflammation, and other chronic inflammatory disorders. By neutralizing or inhibiting PGLYRP1, the antibody helps reduce low-grade inflammation associated with insulin resistance. It is also employed in preclinical studies to validate PGLYRP1 as a drug target and to assess downstream effects on immune cell activation and metabolic pathways. Additionally, this reference antibody serves as a tool for assay development, target engagement studies, and biomarker identification in relevant disease models.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-PGLYRP1 / PGRP-S Reference Antibody (Novo Nordisk patent anti-PGLYRP1)
This antibody is primarily used in therapeutic research targeting inflammatory and metabolic diseases. It modulates the activity of PGLYRP1 (Peptidoglycan Recognition Protein 1), a protein involved in innate immune responses, making it a candidate for treating conditions such as type 2 diabetes, obesity-related inflammation, and other chronic inflammatory disorders. By neutralizing or inhibiting PGLYRP1, the antibody helps reduce low-grade inflammation associated with insulin resistance. It is also employed in preclinical studies to validate PGLYRP1 as a drug target and to assess downstream effects on immune cell activation and metabolic pathways. Additionally, this reference antibody serves as a tool for assay development, target engagement studies, and biomarker identification in relevant disease models.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :